Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 34 Small Cell Lung Carcinoma 14 Triple Negative Breast Neoplasms 12 Breast Neoplasms 9 Ovarian Neoplasms 8 Lung Neoplasms 7 Endometrial Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Esophageal Neoplasms 4 NSCLC 3 Esophageal Squamous Cell Carcinoma 3 Carcinoma 3 Uterine Cervical Neoplasms 2 Recurrence 2 Neoplasms 2 Mouth Neoplasms 2 Laryngeal Neoplasms 2 Fallopian Tube Neoplasms 2 Brain Neoplasms 2 Unresectable Locally Advanced or Metastatic Solid Tumors 1 Thymoma 1 Thymic epithelial tumor 1 Stomach Neoplasms 1 Stage III and IV Ovarian Cancer 1 Squamous Non-small Cell Lung Cancer 1 Squamous NSCLC 1 Solid Tumor Cancer 1 Solid Tumor 1 Salivary Gland Malignant Neoplasms 1 Respiratory Tract Neoplasms 1

Interventions

pembrolizumab 1 decitabine and cedazuridine drug combination 1 cemiplimab 1 Specimen Handling 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Hematologic Tests 1 Etoposide 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Carcinoma, Merkel Cell × Carboplatin × Clear all

NCT06086288 2023-10-17

PANDORA

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Not yet recruiting

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡